Resources and References

The following links provide valuable resources and references on research regulations and ethics:

Ministry of Public and Health
The Ministry of Public Health guidelines, regulations and policies apply to all human subjects research conducted, supported or otherwise subject to regulation by any department of research or research organization in Qatar. This includes research conducted or supported in collaboration with a non-Qatari institution.

The Belmont Report
The Belmont Report summarizes the basic ethical principles identified by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.

  • The Belmont Report (Arabic Version)
    Translation funded by Weill Cornell Medicine - Qatar
    Arabic Language Translator: Professor Hussam Alkhateeb, Qatar National Council for Culture, Arts & Heritage

United States Department of Health and Human Services (DHHS)
The principal US government agency for protecting humans and providing essential health services. Department activities include oversight of health and social science research.

United States Food and Drug Administration (FDA)
Responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, the US national food supply, cosmetics, and products that emit radiation.

  • US FDA Institutional Review Board (IRB) Information Sheets
    These provide recommendations for IRBs, clinical investigators, and sponsors to help them fulfill their responsibilities to protect human subjects participating in FDA-regulated research.
  • US FDA Regulations - Code of Federal Regulations Title 21
    Title 21 of the CFR database details FDA regulations concerning food, drugs, devices and biologics. This includes regulations governing experimental drugs and devices, and their pre-market approval. The CFR Title 21 database is fully searchable. US FDA regulations of special interest:
    • 21 CFR 50 - Regarding protection of human subjects
    • 21 CFR 56 - Regarding institutional review boards
    • 21 CFR 312 - Regarding investigational new drug applications
    • 21 CFR 812 - Regarding investigational device exemptions
    • 21 CFR 312.120 - Regarding foreign clinical studies not conducted under an IND

United States National Institutes of Health (NIH)
The primary US federal agency for conducting and supporting medical research, the NIH provides leadership and financial support to researchers in the US and globally.

World Health Organization (WHO)
The directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends.

Clinical Trials Registries

    A service of the US NIH, is a registry and results database of publicly and privately supported clinical trial research conducted around the world.
  • International Clinical Trials Registry Platform (ICTRP)
    A platform used to inform health care decision making by providing a complete view of clinical trial research, establishing internationally-agreed criteria about design, conduct and administration of clinical trials with the objective to improve transparency and strengthen the validity and value of scientific evidence.
  • World Health Organization (WHO) Registry Network
    In order to take part in the network, the registry requires clinical trials to enter the database prospectively (before the first participant is recruited), and meet ICTRP criteria to demonstrate that the research meets particular standards for content, quality, data validity, accessibility, unique identification, technical capacity and administration.

International Committee of Medical Journal Editors (ICMJE)
The ICMJE publishes resources that specify the uniform requirements for manuscripts submitted to biomedical journals. A number of journals require adherence to these requirements. ICMJE member journals follow the ICMJE clinical trials registration policy.